Medi-Cen Corp. v. Birschbach

720 A.2d 966, 123 Md. App. 765, 1998 Md. App. LEXIS 194
CourtCourt of Special Appeals of Maryland
DecidedNovember 30, 1998
Docket27, Sept. Term, 1998
StatusPublished
Cited by15 cases

This text of 720 A.2d 966 (Medi-Cen Corp. v. Birschbach) is published on Counsel Stack Legal Research, covering Court of Special Appeals of Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medi-Cen Corp. v. Birschbach, 720 A.2d 966, 123 Md. App. 765, 1998 Md. App. LEXIS 194 (Md. Ct. App. 1998).

Opinion

HARRELL, Judge.

The genesis of this appeal is an action brought in the Circuit Court for Montgomery County by H. Robert Birschbach, M.D. Chartered (Dr. Birschbach), appellee, against Medi-Cen Corporation of Maryland (Medi-Cen), appellant. On 8 August 1996, Dr. Birschbach filed a complaint in the circuit court alleging breach of contract and conversion with regard to his share of accounts receivable that Medi-Cen had collected, or was to collect, from medical patients the doctor had treated. *768 Following a bench trial on 15 and 16 April 1997, the court entered judgment in favor of Dr. Birschbach in the amount of $81,739.04, plus prejudgment interest and costs. For purposes of the instant appeal, it appears that the $81,739.04 award was composed of two basic amounts: (a) $28,741.91, representing 50% of the face amount ($57,483.82) of uncollected accounts receivable for medical services rendered prior to contract termination (1 May 1996), and (b) $52,997.13, representing Dr. Birschbach’s share of revenues collected, improper withdrawals, and refunds. As to that judgment, appellant raises in this appeal the following issue which we have rephrased, only as to component (a) of the award:

Whether the trial court erred by awarding the sum of 50% of all outstanding, uncollected accounts receivable for services rendered prior to 1 May 1996.

FACTS

On 29 January 1995, Dr. Birschbach, a physician specializing in internal medicine and gastroenterology, and Medi-Cen, a corporation specializing in administrative billing and marketing services, entered into an Associate Physician Membership Agreement (the Agreement). Pursuant to the Agreement, Medi-Cen was responsible, among other things, for billing and collecting payments from Dr. Birschbach’s patients. 1 Medi-Cen deposited the proceeds collected in a bank account owned by Dr. Birschbach, but accessible by both Dr. Birschbach and Medi-Cen, as provided in the Agreement. As compensation for its performance pursuant to the Agreement, Medi-Cen was entitled to withdraw one-half of the collected funds from the bank account on the fifteenth day of each month. The remaining funds were Dr. Birschbach’s.

In order to enable Medi-Cen to perform its billing and collection undertakings, Dr. Birschbach provided Medi-Cen’s billing service, Health and Quality Management (HQM), with *769 the raw data regarding the services and charges applicable to his patients. Dr. Birschbach kept no copies of this data.

On 26 March 1996, Dr. Birschbach gave Medi-Cen notice that he intended to terminate the Agreement, effective 1 May 1996. Medi-Cen accepted the termination. Both Dr. Birschbach and Medi-Cen assumed that, even after the effective date of termination of the Agreement, Medi-Cen would continue its billing and collection efforts for all services Dr. Birschbach had rendered prior to 1 May 1996 and for which he had provided raw data to HQM. For these services, Medi-Cen would continue to collect its 50% share for all of Dr. Birschbach’s accounts receivable accrued, but unpaid, as of 1 May 1996. 2

Although Medi-Cen continued collecting the accounts receivable, it did not remit to Dr. Birschbach the 50% portion to which he was entitled. In fact, Dr. Birschbach did not receive a payment from Medi-Cen after 30 April 1996.

On 8 August 1996, Dr. Birschbach filed a complaint in the Circuit Court for Montgomery County alleging breach of contract and conversion. 3 After conducting a bench trial on 15 and 16 April 1997, the court found that Medi-Cen had “entirely commandeered [the] accounts receivable as theirs, their property to do with whatever they wish[ed].” Although the court acknowledged that “[t]he record is silent as to whether or not [Medi-Cen] ... ever collected any of that [sic] accounts receivable,” the court found that the record was “not silent on the question on the amount of those accounts receivable, which is doubled $28,741.91.” The court entered judgment in favor of Dr. Birschbach in the amount of $81,739.04, plus prejudgment interest and costs. As noted swpra, the $81,739.04 award included $28,741.91, representing 50% of all outstanding *770 uncollected accounts receivable ($57,483.82) for services rendered prior to 1 May 1996. 4

STANDARD OF REVIEW

Maryland Rule 8-131(c) states:

Action tried without a jury. When an action has been tried without a jury, the appellate court will review the case on both the law and the evidence. It will not set aside the judgment of the trial court on the evidence unless clearly erroneous, and will give due regard to the opportunity of the trial court to judge the credibility of the witnesses.

This Court’s standard of review depends upon whether the lower court’s ruling being scrutinized was a finding of fact or a conclusion of law. Himelstein v. Arrow Cab, 113 Md. App. 530, 536, 688 A.2d 491 (1997), aff'd, 348 Md. 558, 705 A.2d 294 (1998). “[T]he appellate court should not substitute its judgment for that of the trial court on its findings of fact but will only determine whether those findings are clearly erroneous in light of the total evidence.” Van Wyk v. Fruitrade, 98 Md.App. 662, 669, 635 A.2d 14 (1994) (quoting $3,11746 U.S. Money v. Kinnamon, 326 Md. 141, 149, 604 A.2d 64 (1992)). In contrast, the clearly erroneous standard does not apply to the trial court’s determinations of legal questions or to the legal conclusions it draws from its factual findings. Id. (citing Davis v. Davis, 280 Md. 119, 124, 372 A.2d 231 (1977)). The appropriate standard of review in these instances is whether the trial court was legally correct. Himelstein, 113 Md.App. at 536, 688 A.2d 491.

DISCUSSION

In order to resolve the parties’ dispute as to whether the trial court’s award to Dr. Birschbach of 50% of the face value of all outstanding, uncollected accounts receivable was correct, *771 we must examine three issues. Initially, we must determine a definition of “accounts receivable.” Second, using this definition, we must analyze whether accounts receivable are property subject to conversion. Finally, if accounts receivable are subject to conversion, we must determine if the circuit court properly valued such property for purposes of the instant conversion action.

A.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Yah Kai World Wide Enters., Inc. v. Napper
292 F. Supp. 3d 337 (D.C. Circuit, 2018)
Aliya Medcare Finance, LLC v. Nickell
156 F. Supp. 3d 1105 (C.D. California, 2015)
Thompson v. UBS Financial Services, Inc.
115 A.3d 125 (Court of Appeals of Maryland, 2015)
American Master Lease v. Idanta Partners
California Court of Appeal, 2014
American Master Lease LLC v. Idanta Partners, Ltd.
225 Cal. App. 4th 1451 (California Court of Appeal, 2014)
American Master Lease v. Idanta Partners CA2/7
California Court of Appeal, 2014
Thomas v. Capital Medical Management Associates, LLC
985 A.2d 51 (Court of Special Appeals of Maryland, 2009)
Al Gailani v. Riyad Bank, Houston Agency
144 S.W.3d 1 (Court of Appeals of Texas, 2003)
Maryland Environmental Trust v. Gaynor
780 A.2d 1193 (Court of Special Appeals of Maryland, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
720 A.2d 966, 123 Md. App. 765, 1998 Md. App. LEXIS 194, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medi-cen-corp-v-birschbach-mdctspecapp-1998.